2014 - 2016 Constraction of basis of glioblastoma treatment targeting for GSK3beta
2012 - 2014 Basic base constraction of malignant glioma therapy targeting for GSK3beta
Show all
Papers (50):
Yasuo Sugita, Takuya Furuta, Kenji Takahashi, Koichi Higaki, Yuichi Murakami, Michihiko Kuwano, Mayumi Ono, Hideyuki Abe, Jun Akiba, Motohiro Morioka. Elevated expression of N-myc downstream regulated gene 1 protein in glioblastomas reflects tumor angiogenesis and poor patient prognosis. Neuropathology : official journal of the Japanese Society of Neuropathology. 2024
Mayuko Moritsubo, Takuya Furuta, Junko Miyoshi, Satoru Komaki, Kiyohiko Sakata, Hiroaki Miyoshi, Motohiro Morioka, Koichi Ohshima, Yasuo Sugita. Increased expression of leucine-rich α-2 glycoprotein 1 as a predictive biomarker of favorable progression-free survival in meningioma. Neuropathology : official journal of the Japanese Society of Neuropathology. 2024. 44. 2. 96-103
Mayuko Moritsubo, Takuya Furuta, Tetsuya Negoto, Hideo Nakamura, Yusuke Uchiyama, Motohiro Morioka, Koichi Oshima, Yasuo Sugita. A case of a pilocytic astrocytoma with histological features of anaplasia and unprecedent genetic alterations. Neuropathology : official journal of the Japanese Society of Neuropathology. 2024. 44. 2. 161-166
Mai Takeuchi, Hiroaki Miyoshi, Yuichiro Semba, Kyohei Yamada, Kazutaka Nakashima, Kensaku Sato, Takuya Furuta, Mayuko Moritsubo, Yusuke Ogura, Ken Tanaka, et al. Co-stimulatory and immune checkpoint molecules are important in the tumor microenvironment of Hodgkin-like adult T-cell leukemia/lymphoma. Haematologica. 2023. 108. 12. 3496-3501
Takuya Furuta, Tetsuya Negoto, Hiroaki Miyoshi, Mayuko Moritsubo, Hideo Nakamura, Motohiro Morioka, Jun Akiba, Koichi Ohshima, Yasuo Sugita. Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas. Journal of neuro-oncology. 2023. 164. 3. 633-641